CRL vs ICLR stock comparison
Charles River Laboratories International vs. Icon · data as of November 13, 2026
Charles River Laboratories International (CRL) has a market value of about $16.2B, Icon (ICLR) about $14.9B. Over their latest twelve months Charles River Laboratories International had revenue of $4.0B and Icon $8.2B.
On our five checks Icon scores higher: 1.8 out of 5 (weak) against 1.2 (weak).
By area, the stronger company is Icon on value; Icon on track record; Icon on financial health; Charles River Laboratories International on shareholder returns.
Icon is cheaper on earnings (P/E 77.9 vs. 367.4).
Charles River Laboratories International leads on 3 of the compared lines and Icon on 17.
Side by side
| CRL | ICLR | |
|---|---|---|
| Size and price | ||
| Market cap | $16.2B | $14.9B |
| Share price | $337.97 | $194.65 |
| Score | ||
| Overall score (of 5) | 1.2 | 1.8 |
| Value | 0 | 1 |
| Future growth | 1 | 1 |
| Track record | 0 | 2 |
| Financial health | 2 | 3 |
| Shareholder returns | 3 | 2 |
| Valuation | ||
| P/E (TTM) | 367.4 | 77.9 |
| Forward P/E | 26.7 | 17.2 |
| Price / free cash flow | 40.5 | 17.4 |
| Price / sales | 4.1 | 1.8 |
| EV / EBITDA | 42.4 | 36.1 |
| PEG | — | — |
| DCF value vs. price | −76% | −27% |
| Business | ||
| Revenue | $4.0B | $8.2B |
| Net income | $40M | $449M |
| Free cash flow | $400M | $857M |
| Net margin | 1.0% | 5.4% |
| Gross margin (5-yr avg.) | — | 28.4% |
| ROIC (5-yr avg.) | 5.6% | 4.9% |
| Growth | ||
| Revenue growth (1 yr) | -0.9% | 0.8% |
| Revenue growth (5 yrs, per year) | 6.6% | 24.1% |
| EPS growth (5 yrs, per year) | — | -14.0% |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$2.7B | -$2.7B |
| Dividend yield | None | None |
| Shareholder yield | 2.2% | 5.0% |
| Analysts | ||
| Upside to average target | +4% | +19% |
| Consensus rating | Buy | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: CRL TTM to September 26, 2026, ICLR TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Charles River Laboratories International or Icon?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Icon scores 1.8 out of 5 and Charles River Laboratories International 1.2; the table shows where each one is stronger.
Is Charles River Laboratories International cheaper than Icon?
On trailing earnings, Icon trades at a P/E of 77.9 and Charles River Laboratories International at 367.4, so Icon is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, Charles River Laboratories International or Icon?
Over five years Icon grew revenue about 24.1% a year and Charles River Laboratories International about 6.6% a year.
Full Charles River Laboratories International analysis → Full Icon analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.